Tirapazamine: a novel agent targeting hypoxic tumor cells.

Reddy, Srini B; Williamson, Stephen K

Reddy, Srini B; Williamson, Stephen K.

Affiliation

Reddy SB; University of Kansas Medical Center, Division of Hematology/Oncology, 2330 Shawnee Mission Parkway, Suite 210, Westwood, KS 66205, USA.

Expert Opin Investig Drugs ; 18(1): 77-87, 2009 Jan.

Article in En | MEDLINE | ID: mdl-19053884

Subject(s)

Antineoplastic Agents/therapeutic use; Neoplasms/drug therapy; Neoplasms/pathology; Triazines/therapeutic use; Animals; Antineoplastic Agents/adverse effects; Antineoplastic Agents/chemistry; Cell Hypoxia/drug effects; Clinical Trials as Topic; Humans; Neoplasms/metabolism; Tirapazamine; Treatment Outcome; Triazines/adverse effects; Triazines/chemistry

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triazines / Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Expert Opin Investig Drugs Journal subject: TERAPIA POR MEDICAMENTOS Year: 2009 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google